ME / CFS and the BEMER 3000

Myalgic Encephalomyelitis (M.E.) also referred to as Myalgic Encephalopathy or Chronic Fatigue Syndrome (CFS) is a serious, debilitating and complex illness that affects multiple systems in the body

How may patients obtain relief with the BEMER 3000 therapy system?

Symptoms of the disease may include severe prolonged fatigue, post-exertional malaise, sleep disturbances, multiple pain syndromes in the region of the head, neck, lymph nodes, muscles, joints and other areas, possible disturbances to neurological and cognitive function, poor concentration and short term memory, autonomic nervous system problems such as orthostatic intolerance, breathing and heart irregularities and dysfunction of the gut, neuro-endocrine disturbances such as changes to the control of body temperature and weight changes, and disturbances of the immune system.

As the complaints are non-specific and initially can be considered as symptoms of many different clinical pictures, careful diagnostic clarification in keeping with a well-defined procedure for excluding different diseases is essential.

Because of the unclear origin of the disease, the use of BEMER 3000 Therapy can be regarded as an effective symptom-related therapy. The complex effective mechanisms of BEMER 3000 therapy have been scientifically demonstrated in many clinical-medical studies, and are listed below. Aside from symptomatic treatment, they could form an important basis for causative treatment:

Affect on Symptoms and Illness conditions

How the BEMER 3000 assists ME/CFS sufferers

As a rule, CFS patients also show permanent weakness of the immune system and greatly increased susceptibility to stress even when taking medications. In the initial stage, the illness frequently follows a sudden flu-like course, followed by different lengths of various pronounced phases involving impairment of physical and mental performance, even leading to the being confined to bed.

It is here that the BEMER 3000 is an effective management strategy. Recent trials confirmed the increase in white blood cell adhesion – leading to the strengthening of the immune system. The increases in blood circulation, as well as the complex effects shown in the opposite column allow the patient greater mobility, energy, and assistance in recovering from exercise or exertion.

Further, therapy reduces stress, acidity and allows the patient to develop a sound sleeping pattern.

On the basis of the individual reports and numerous experiences with similar clinical pictures, it can be assumed that through the sum of the reactions and established effects, such as the acceleration of general regeneration, strengthening or stabilization of the immune system and relief from pain conditions, the clinical picture of CFS can be influenced positively and the body is assisted in its ability to self-regulate and self-heal.

1. Increase in the preparedness of molecular and sub-molecular structures in the organism through a broadband form of signal [unique to date], where a broad spectrum of chemical reaction processes is facilitated (Kafka, W. A.)

2. Activation of HSP 70, the result of which is a synthesis of special repair proteins (Jelinek, R.),

3. Improvement in blood circulation, blood microcirculation, the result of which is an increase in the oxygen partial pressure (Michaelis, H.) and the separation of erythrocyte clusters (Malkomes, Ch.) in the blood.

4. Improved metabolism of red blood corpuscles by filling ATP and other energy-rich phosphate depots (Spodaryk, K.)

5. Lowered blood pressure, reduced the pulse rate and vegetative relaxation (Michels-Weikili, S.).

 

  BEMER 3000 Recommendations and Therapy

There are too many variables regarding the individual clinical picture to be able to undertake a representative evaluation of the use and application of BEMER 3000 therapy, therefore patients should consult a BEMER 3000 practitioner or contact the HOTLINE for a personal therapy program to suit individual needs.

As a general rule, to slowly build up the metabolism, all patients should begin as indicated in the table opposite. >>

ME/CFS may show different “faces” and it is therefore sensible to constantly check the application of both conventional treatment methods and BEMER Therapy constantly to adjust to new conditions and to integrate this into the treatment.

 

BEMER 3000 Mat

BEMER 3000 SLT

Morning

BP from M1

Fixed Program 1

Afternoon

BP

Fixed Program 1

Evening

M1

User Program 1

 

Twice a day use the BEMER 3000 according to the Basic Program commencing at Level 1, or Fixed Program 1 [SLT] and weekly increase from 1 to 5.

User results

    Reduction in Medication

“Ten years ago I was diagnosed with ME/CFS.  I suffered from this for 4 years prior to diagnosis which to a certain extent left me debilitated.  From time to time I still feel the effects of the illness.  With the introduction of the BEMER Therapy - using it once a day for 8 minutes - it has turned my life around!

It has helped me to function normally again without feeling fatigued as I normally would before I started using the BEMER 3000.  Bear in mind too, that I am now 10 years older than I was before the illness.

I have now been able to join a gym and work 12+ hours a day without feeling fatigued and tired.  I wake up with energy and have a sense of well being every day.  All of this thanks to BEMER Therapy.” -  I.P.W

It is also the case that those ill with CFS as a rule react very sensitively to pharmaceutical drugs, which is why it is necessary to work with much lower doses than usual.

As BEMER 3000 Therapy contributes to an improvement in the Metabolisation of medication, it may be possible to reduce the medication further [after consulting with a physician].

It is essential to note that if excessive acidification of the tissues is established, it is sensible to take basic mineral supplements, change diet, and allow plenty of rest.

 

In a medical users' study of 220 clinics led by the Academy for Bioenergetics, the effect of BEMER Therapy was documented. A total of 2031 cases of illness were recorded, of which 223 met the criteria of ME/CFS. The average treatment period was 6 weeks.

Results:

General wellbeing: 74 % Experienced significant improvement, or were symptom free; and 19 % recorded an improvement in their condition, achieving a success rate of 93%.

 

   

Literature: 1. Spodaryk, K. Metabolism of red blood particles and the hemoglobin-oxygen affinity. Institute for rehabilitation, AWF, Krakow, Poland.2. Michaelis, H., Technical Information BEMER3000 - Therapy, Academy for Bioenergetics, 5/99. 3. Klopp, R. Research with vital microscopic and reflection spectrometry to determine the improvement of human microcirculation under the influence of BEMER 3000 type pulsed electromagnetic fields, Institute of Microcirculation, Berlin, 2004. 4. Orthopaedic Practice, 41, January 2005. Extremely wide (BEMER type) pulsed weak electromagnetic fields in Orthopaedic applications.

TGA Aust L 97096; EC 93/42/EWG; CE O125 While the product is registered as a medical device in Australia, NZ, and the EU, no medical claims as yet are made  or implied concerning use or application in the USA

Academy for Bioenergetics / ME/CFS - Info / © Innomed Bemer Clinics Pty Ltd 2006 ABN 89 105 311 840